title: Clinical trials of endothelin antagonists in heart failure: publication is good for the public health.
abstract: The failure of endothelin antagonists to show benefit in heart failure cannot be understood until all the clinical trials are fully published.
authors.forename: N F
authors.initials: NF
authors.lastname: Kelland
authors.forename: D J
authors.initials: DJ
authors.lastname: Webb
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D065130:Endothelin A Receptor Antagonists; D019332:Endothelin-1 / Q000502:physiology; D019317:Evidence-Based Medicine; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D011643:Publishing
chemical_list: D000959:Antihypertensive Agents; D065130:Endothelin A Receptor Antagonists; D019332:Endothelin-1